OOIR: Observatory of International Research

Papers

(The TQCC of Pituitary is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	85
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	68
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	42
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	38
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	36
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	36
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	32
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	31
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	29
Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review	27
Pituitary: hic manebimus optime	24
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	24
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	24
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	23
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	23
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	22
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	22
Machine learning as a clinical decision support tool for patients with acromegaly	22
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	21
Pituitary metastases: a case series and scoping review	21
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	21
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	21
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	19
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	18
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	18

Genetic models of Cushing’s disease	18
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	18
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	18
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	18
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	17
Normative data for pituitary size and volume in the general population between 50 and 66 years	17
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	17
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	17
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	16
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	16
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	16
TSH-secreting pituitary adenomas and bone	15
IGF-1 is positively associated with BMI in patients with acromegaly	15
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	15
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	14
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	14
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	14
Cushing’s disease and bone	14
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	14
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	14
Pituitary surgery and COVID	13
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	13
Copeptin after pituitary surgery: is it worth measuring?	13
Acromegaly is associated with a distinct oral and gut microbiota	13
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis	13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	13
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	12
Is diabetes with acromegaly for life?	12
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	12
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	12
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	11
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	11
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	11
Characterization of a paradoxical post-operative increase in serum cortisol in Cushing disease	11
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	11
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	11
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	11
Long COVID and pituitary dysfunctions: a bidirectional relationship?	11
Mental health disorders in newly diagnosed non-functional pitutary adenoma under initial observation: an observational cohort study using the nationwide MarketScan database	11
Refractory nonfunctioning pituitary adenomas	11
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	11
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	10
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	10
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	10
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	10
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	10
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	10
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	10
Skeletal fragility in pituitary disease: how can we predict fracture risk?	10
Low prevalence of neuropathic-like pain symptoms in long-term controlled acromegaly	10

Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	10
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	10
Cushing’s disease: role of preoperative and primary medical therapy	10
Correction: consensus on criteria for acromegaly diagnosis and remission	9
An update on, and genetics of refractory adenomas of childhood	9
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	9
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	9
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	9
Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing’s disease	9
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	9
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	9
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	9
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	9
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	8
Giant prolactinomas, a detailed analysis of 196 adult cases	8
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	8
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	8
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	8
How to manage intolerance to dopamine agonist in patients with prolactinoma	8
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	8
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	8
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	8
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis	8